Jump to Content

Economics Staff Listing

Dr Ronan Mahon

B.Sc., M.Sc., PhD

Contact Details

Lecturer Above The Bar
J.E Cairnes School of Business & Economics
University of Galway
E: Ronan.Mahon@universityofgalway.ie

Biography

Dr Mahon is a Lecturer Above the Bar in the Discipline of Economics at University of Galway. He is currently Programme Director for the MSc in Health Economics. His research focuses primarily on Health Economic Evaluation. He is a member of the National Screening Advisory Committee of Ireland and a member of the Health Economics Association of Ireland Executive Committee.

Peer Reviewed Journals

	Year	Publication
	(2024)	'Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison' Mahon, R., Tiwari, S., Heemstra, H., Koch, M., Ferraris, M., Betts, K., Wang, Y., Gao, S. (2024) 'Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison'. Journal of Comparative Effectiveness Research, 13 (3) [DOI] [Details]
	(2022)	'Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine' Mahon, R., Vo, P., Pannagl, K., Tiwari, S., Heemstra, H., Ferraris, M., Zhao, J., Betts, K.A. and Proot, P. (2022) 'Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine'. Current Medical Research And Opinion, 39 (1) [Details]
	(2021)	'Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden' Mahon, R., Lang, A., Vo, P., Huels, J., Cooney, P., Danyliv, A., Vudumula, U., Vadapalle, S., Maniyar, F. and Goadsby, P.J. (2021) 'Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden'. Pharmacoeconomics, 39 [Details]
	(2020)	'Economic evaluations in migraine: systematic literature review and a novel approach' Mahon, R., Huels, J., Hacking, V., Cooney, P., Danyliv, A., Vudumula, U., Vadapalle, S., Vo, P., Maniyar, F.H., Palmer, S. and Goadsby, P.J. (2020) 'Economic evaluations in migraine: systematic literature review and a novel approach'. Journal Of Medical Economics, 23 (8) [Details]
	(2017)	'Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population' Bjermer, L., van Boven, J.F., Costa-Scharplatz, M., Keininger, D.L., Gutzwiller, F.S., Lisspers, K., Mahon, R., Olsson, P. and Roche, N., (2017) 'Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population'. Respiratory Research, 18 [Details]
	(2017)	'How to appropriately extrapolate costs and utilities in cost-effectiveness analysis' Bojke, L., Manca, A., Asaria, M., Mahon, R., Ren, S. and Palmer, S. (2017) 'How to appropriately extrapolate costs and utilities in cost-effectiveness analysis'. Pharmacoeconomics, 35 [Details]

Other Journals

	Year	Publication
	(2016)	'Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema' Kourlaba, G; Relakis, J; Mahon, R; Kalogeropoulou, M; Pantelopoulou, G; Kousidou, O; Maniadakis, N. (2016) 'Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema' Cost Effectiveness and Resource Allocation, 14 . [Details]
	(2020)	'Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach' Lakhotia, B., Mahon, R., Gutzwiller, F.S., Danyliv, A., Nikolaev, I. and Thokala, P., (2020) 'Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach' International Journal of Chronic Obstructive Pulmonary Disease, 15 . [Details]

Professional Associations

	Association	Function	From / To
	The Professional Society for Health Economics and Outcomes Research (ISPOR)	Member	/

Committees

	Committee	Function	From / To
	National Screening Advisory Committee	Committee member	/
	Health Economics Association of Ireland	Executive committee member	/

Education

Year	Institution	Qualification	Subject
2010	University of Edinburgh	M.Sc.	Operational Research
2015	University of York	Ph.D.	Economics
2006	University of Galway	B.Sc.	Financial Mathematics and Economics